CAS NO: | 256922-53-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | CL075 (3M002) is a selectiveTLR8agonist with immunomodulating properties. CL075 triggers a MyD88-dependent signaling pathway to elicit production of inflammatory cytokines and type I interferons (IFNs) via activation ofNF-κBand IRF7, respectively[1][2][3]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | CL075 (2 μM; 4 h) induces the production of IL-6, IL-8, and IFN-γ in rabbit splenocytes[1]. | ||||||||||||||||
体内研究 (In Vivo) | CL075 (5 μM (0.5 mL); s.c.) activates a mild antigen-specific antibody response in rabbits[1]. | ||||||||||||||||
分子量 | 243.33 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C13H13N3S | ||||||||||||||||
CAS 号 | 256922-53-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 22 mg/mL(90.41 mM;Need ultrasonic and warming) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |